Browse CRS Products

Filter

Topic

All

Abortion

Accounting & Auditing

Administrative Procedure Act (APA)

Affordable Care Act (ACA)

Afghanistan & Pakistan

Agency for Healthcare Research & Quality (AHRQ)

Agency for Toxic Substances & Disease Registry (ATSDR)

Agricultural Conservation Appropriations

Agricultural Technology & Research

Agricultural Trade

Agricultural Trade & Food Aid

Agriculture Appropriations

Agriculture Budget & Appropriations

Air & Missile Defense (AMD)

Air Quality

Air, Land, Sea, Space & Projection Forces

Alaska

Animal Agriculture

Appropriations

Appropriations Policy

Architect of the Capitol (AOC)

Arms Control & Nonproliferation

Artificial Intelligence

Asylees, Refugees & Other Humanitarian Concerns

Auditing Standards & Regulation

Aviation

Banking

Bankruptcy

Base Realignment & Closure (BRAC)

Biometrics

Biosafety & Biosecurity

Bolivia

Border Security

Border Security Between Ports of Entry

Border Security at Ports of Entry

Budget & Appropriations Procedure

Budget Reconciliation

Bureau of Indian Education (BIE)

Burial Benefits, National Cemeteries & Memorials

Business & Corporate Tax

Campaign Finance

Capital Gains Tax

Carbon Capture & Sequestration (CCS)

Career-Related Education & Training

Cash Assistance

Census

Center for Medicare and Medicaid Innovation (CMMI)

Central America

Central America and the Caribbean

Central Asian States

Charter Schools

Child Nutrition Programs

Child Support & Family Formation

Child Welfare

China

Civil Liberties & National Security

Civil Rights & Liberties

Clean Air Act (CAA)

Climate Change

Climate Change & Greenhouse Gas Control Legislation

Colleges & Universities

Colombia

Commemorations

Commerce, Justice, Science Appropriations

Commercial Space Industry

Commercial Space Policy

Committee Rules

Competition Policy & Law

Congressional Bill Introduction

Congressional Commissions

Congressional Committee Rules & Procedure

Congressional Committees

Congressional Communications, Publications & Documents

Congressional Ethics & Lobbying

Congressional Funding

Congressional Leadership

Congressional Operations

Conservation & Natural Resources

Consumer Credit Reporting

Consumer Finance Protection

Continuing Appropriations

Controlled Substances Act (CSA)

Corporation for National & Community Service (CNCS)

Crime

Criminal Justice

Criminal Justice Reform

Critical Infrastructure

Customs & Border Protection (CBP)

Cybercrime & Technology

Cybersecurity

DHS Structure & Management

Deep Fakes

Defense & Intelligence

Defense Acquisitions

Defense Appropriations

Defense Authorization

Defense Budgets & Appropriations

Defense Readiness, Training, Logistics & Installations

Deferred Action for Childhood Arrivals (DACA)

Author

All

Abigail A. Graber

Abigail F. Kolker

Abigail R. Overbay

Ada S. Cornell

Adam C. Nesbitt

Adam G. Levin

Adam K. Edgerton

Adam Stoll

Adam Vann

Adrienne L. Fernandes-Alcantara

Agata Bodie

Agata Dabrowska

Alejandra Aramayo

Alexa C. DeBoth

Alexander H. Pepper

Alexandra G. Neenan

Alexandra Hegji

Alexandria K. Mickler

Alexis Arieff

Alexis N. Boytim

Ali E. Lohman

Alice B. Grossman

Alice Y. Choi

Alicyn R. Gitlin

Alison M. Smith

Alison Mitchell

Alison Siskin

Alyse N. Minter

Alyssa K. King

Alyssa R. Casey

Amanda H. Peskin

Amanda K. Sarata

Amber D. Nair

Amber Hope Wilhelm

Andorra Bruno

Andrea M. Muto

Andreas Kuersten

Andres B. Schwarzenberg

Andrew Feickert

Andrew Nolan

Andrew P. Scott

Andrew S. Bowen

Andrew S. Coghlan

Andrew Tilghman

Angela C. Jones

Angela Napili

Angele A. Gilroy

Anita Regmi

Anna E. Normand

Anne A. Riddle

Anthony A. Cilluffo

Anthony R. Marshak

Anya L. Fink

April J. Anderson

Ashley J. Lawson

Audrey Celeste Crane-Hirsch

Audrey L. Singer

Audrey Singer

Baird Webel

Barbara L. Schwemle

Barbara Salazar Torreon

Barry F. Huston

Barry J. McMillion

Bart Elias

Ben Dolven

Ben Goldman

Ben Harrington

Ben Leubsdorf

Ben Wilhelm

Benjamin B. Wilhelm

Benjamin Collins

Benjamin Hayes

Benjamin M. Barczewski

Benjamin Tsui

Bernadette Fernandez

Betsy A. Cody

Bill Canis

Bill Heniff Jr.

Boris Granovskiy

Brandon J. Murrill

Brandon S. Tracy

Brendan McDermott

Brendan W. McGarry

Brent D. Yacobucci

Brian E. Humphreys

Brian T. Yeh

Bruce E. Foote

Bruce R. Lindsay

Bryan L. Adkins

Bryce H. P. Mendez

C. Stephen Redhead

Caitlin Campbell

Caitlin Curran

Caitlin Keating-Bitonti

Calvin Gibson

Cameron M. Keys

Carla Berry

Carla Y. Davis-Castro

Carly A. Miller

Carol Canada

Clear

Sort By

Title Date ↓ Type

Expiring Health Provisions of the 119th Congress

2025-09-24 · Reports · R48649 · HTML available · PDF available

Food and Dietary Supplement Labeling Claims: FDA Regulation and Select Legal Issues

2025-08-12 · Reports · R48623 · HTML available · PDF available

Preterm Infant Formula and Necrotizing Enterocolitis Litigation

2025-08-04 · Posts · IN12591 · HTML available · PDF available

Recent Supreme Court Decisions Related to ECigarette Regulation

2025-07-03 · Posts · LSB11334 · HTML available · PDF available

Pharmaceutical Patent Disputes: Generic Entry for Small-Molecule Drugs Under the Hatch-Waxman Act

2025-06-12 · Resources · IF13028 · HTML available · PDF available

Pharmaceutical Patent Disputes: Biosimilar Entry Under the Biologics Price Competition and Innovation Act (BPCIA)

2025-06-12 · Resources · IF13029 · HTML available · PDF available

District Court Rules FDA Lacks Authority to Regulate Laboratory Developed Tests

2025-05-19 · Posts · LSB11312 · HTML available · PDF available

Finding Medical Device and Drug Approval Information Through the Food and Drug Administration Databases

2025-05-19 · Reports · R48133 · HTML available · PDF available

U.S. Food and Drug Administration (FDA) Regulation of Electronic Nicotine Delivery Systems (ENDS): Background and Selected Policy Issues

2025-04-04 · Reports · R48483 · HTML available · PDF available

NIH Indirect Costs Policy for Research Grants: Recent Developments

2025-03-03 · Posts · IN12516 · HTML available · PDF available

The Vaccine Adverse Events Reporting System: Understanding the Data

2025-01-16 · Posts · IN12486 · HTML available · PDF available

FDA Regulation of Laboratory-Developed Tests (LDTs)

2025-01-14 · Resources · IF11389 · HTML available · PDF available

The National Institutes of Health (NIH): Background and Congressional Issues

2025-01-13 · Reports · R41705 · HTML available · PDF available

Artificial Intelligence (AI) in Health Care

2024-12-30 · Reports · R48319 · HTML available · PDF available

Patent Listing in FDA’s Orange Book

2024-12-27 · Resources · IF12644 · HTML available · PDF available

Cybersecurity and Digital Health Information

2024-12-04 · Resources · IF12591 · HTML available · PDF available

Ultra-Processed Foods (UPF): Background and Policy Issues

2024-11-22 · Resources · IF12826 · HTML available · PDF available

Over-The-Counter Monograph Drug User Fee Program (OMUFA) Reauthorization

2024-11-20 · Resources · IF12821 · HTML available · PDF available

Health Claims on Food and Dietary Supplement Labels: FDA Regulation and Select Legal Issues

2024-10-31 · Resources · IF12801 · HTML available · PDF available

Novel Gene Therapies for Blood Disorders

2024-10-25 · Resources · IF12796 · HTML available · PDF available

FDA Regulation of Tampons

2024-10-11 · Posts · IN12441 · HTML available · PDF available

Legal Effect of Marijuana Rescheduling on FDA’s Regulation of Cannabis

2024-09-16 · Posts · LSB11227 · HTML available · PDF available

Xylazine and the Controlled Substances Act: Legal Considerations for Congress

2024-07-19 · Posts · LSB11202 · HTML available · PDF available

National Institutes of Health (NIH) Funding: FY1996-FY2025

2024-06-25 · Reports · R43341 · HTML available · PDF available

The Federal Status of Marijuana and the Policy Gap with States

2024-05-02 · Resources · IF12270 · HTML available · PDF available

FDA Human Medical Product User Fee Programs

2024-04-26 · Reports · R44750 · HTML available · PDF available

Regulation of Laboratory-Developed Tests: FDA’s Proposed Rule

2024-04-08 · Resources · IF12628 · HTML available · PDF available

Vanda Pharmaceuticals, Inc. v. United States: Fifth Amendment Takings Claims for Alleged Disclosures of Trade Secrets and Confidential Information

2024-04-08 · Posts · LSB11143 · HTML available · PDF available

Circuit Split over the Food and Drug Administration’s Denial of Applications Seeking to Market Flavored E-Cigarettes, Part 1 of 2

2024-04-05 · Posts · LSB11141 · HTML available · PDF available

Circuit Split over the Food and Drug Administration’s Denial of Applications Seeking to Market Flavored E-Cigarettes, Part 2 of 2

2024-04-05 · Posts · LSB11142 · HTML available · PDF available

The Orphan Drug Act: Legal Overview and Policy Considerations

2024-03-05 · Resources · IF12605 · HTML available · PDF available

The Role of Patents and Regulatory Exclusivities in Drug Pricing

2024-01-30 · Reports · R46679 · HTML available · PDF available

Prescription Drug Importation

2024-01-22 · Resources · IF11056 · HTML available · PDF available

Animal Use in Federal Biomedical Research: A Policy Overview

2023-12-28 · Resources · IF12002 · HTML available · PDF available

Expired and Expiring National Institutes of Health (NIH) Provisions

2023-12-06 · Posts · IN12173 · HTML available · PDF available

Kratom Regulation: Federal Status and State Approaches

2023-11-28 · Posts · LSB11082 · HTML available · PDF available

FDA Regulation of Cosmetics and Personal Care Products Under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA)

2023-10-30 · Reports · R47826 · HTML available · PDF available

The Cancer Moonshot: Overview and Issues

2023-09-29 · Resources · IF12504 · HTML available · PDF available

Naloxone for Opioid Overdose: Considerations for Congress

2023-09-11 · Resources · IF12490 · HTML available · PDF available

The Orphan Drug Act and Catalyst Pharmaceuticals, Inc., v. Becerra

2023-08-17 · Reports · R47653 · HTML available · PDF available

PREVENT Pandemics Act (P.L. 117-328, Division FF, Title II)

2023-08-15 · Reports · R47649 · HTML available · PDF available

Xylazine: Considerations for Federal Control

2023-08-01 · Posts · IN12086 · HTML available

Medical Product Regulation: Drugs, Biologics, and Devices

2023-05-26 · Resources · IF11083 · HTML available · PDF available

Advanced Research Projects Agency for Health (ARPA-H): Overview and Selected Issues

2023-05-23 · Reports · R47568 · HTML available · PDF available

FDA Regulation of Medical Devices

2023-01-04 · Reports · R47374 · HTML available · PDF available

The Food and Drug Administration (FDA) Budget: Fact Sheet

2022-12-09 · Reports · R44576 · HTML available · PDF available

Prescription Drug Discount Coupons and Patient Assistance Programs (PAPs)

2022-09-12 · Reports · R44264 · HTML available · PDF available

Infant Formula Shortage: FDA Regulation and Federal Response

2022-05-21 · Resources · IF12123 · HTML available · PDF available

The Evolution of Marijuana as a Controlled Substance and the Federal-State Policy Gap

2022-04-07 · Reports · R44782 · HTML available · PDF available

Synthetic Nicotine: Frequently Asked Questions

2022-02-28 · Reports · R47043 · HTML available · PDF available